flipper44,
And during that same time many of those seeking to imply bad things about NWBO or their directors had problems of their own. The ex CEO of Cenkos, friend of Mr. Neil Woodford, unceremoniously disappeared from his position after a run in with NWBO Director and investor recruitor Dr Navid Malik. Ms Katherine Wolf, Ondra Partners full partner and overly interested party in all things NWBO confidential, was called out, had the notes she took returned but apparently not until Mt. Woodford or his fund managers had a peek. She unceremoniously left Ondra after being stripped of her partner status and Mr. Woodford was stripped of his duties with the fund he ran later on which was subsequently liquidated driving NWBO share price down with it, he being thus distanced perhaps so that he would not go to jail for trading on non public information about NWBO.
All this combined with a trial that fully enrolled all treatment patients but was deliberately left under enrolled by regulators, with 17 missing SOC/placebo patients, who then had to point the finger at NWBO in order to lift the hold when they agreed not to enroll any more patients which subsequently led to the first sign of production ramp up that you mention.
Yes flipper44, the picture becomes much clearer when the pixels are brought closer together ; ). Best wishes.
AI
Market Data 
Markets 
